@thetruism · 14d ago
Study finds psilocybin protects against nerve damage from chemotherapy
A new study has found that psilocybin, the active compound in psychedelic mushrooms, may help protect against nerve damage and peripheral neuropathy caused by chemotherapy treatment.
Not moving quickly right now, but still current and open to further updates.
What we know
Global
Study finds psilocybin protects against nerve damage from chemotherapy
- Psilocybin protects against nerve damage caused by chemotherapy
- The study demonstrating psilocybin's protective effect against chemotherapy-induced nerve damage was conducted on mice.
5
Sources
0
Primary
0
Corroborated
Moderate
Evidence
Where this comes from
Shared inside The Truism
No one has shared this event with commentary yet. Sharing adds context around the record — it never changes it.
Comments
Live updates
No developments recorded since this event was first published.
One living record. This page is revised as evidence arrives — it is never republished as a new article.
What we know
Developing
What we don't know
Open questions are tracked here until evidence answers them. The Truism never fills a gap with an assumption.
- Whether the protective effects observed in the study will translate successfully to human clinical trials.
- The exact cellular mechanisms by which psilocybin prevents nerve degeneration.
- The study’s identity, publication venue and peer-review status.
- The experimental design, sample size, chemotherapy agent, psilocybin dose and timing.
- Which outcomes were measured and whether they reflected prevention, reduced symptoms or reduced nerve degeneration.
- Whether adverse effects or other safety findings were reported.
- Whether any human evidence exists; the supplied material establishes only an unverified claim about a mouse study.
Update & correction history
No developments recorded since this event was first published.
The record is never silently rewritten. Every change is logged.
Loading comments…